buspirone has been researched along with psilocybin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kraehenmann, R; Pokorny, T; Preller, KH; Vollenweider, FX | 1 |
Botvinnik, A; Lerer, B; Lifschytz, T; Lotan, A; Saban, M; Salama, A; Shahar, O; Singh, S; Wolf, G; Yakobi, C | 1 |
1 trial(s) available for buspirone and psilocybin
Article | Year |
---|---|
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Topics: Behavior Rating Scale; Buspirone; Consciousness Disorders; Double-Blind Method; Ergotamine; Female; Hallucinogens; Healthy Volunteers; Humans; Male; Psilocybin; Serotonin Receptor Agonists; Young Adult | 2016 |
1 other study(ies) available for buspirone and psilocybin
Article | Year |
---|---|
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Escitalopram; Hallucinogens; Male; Mice; Mice, Inbred ICR; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT1A; Serotonin | 2023 |